Macrogen, Inc. (KOSDAQ: 038290)

Market Cap	166.55B
Revenue (ttm)	131.73B
Net Income (ttm)	-21.73B
Shares Out	9.98M
EPS (ttm)	-2,175.92
PE Ratio	n/a
Forward PE	50.92
Dividend	300.00 (1.80%)
Ex-Dividend Date	Dec 27, 2024

Volume	18,499
Average Volume	24,850
Open	16,700
Previous Close	16,700
Day's Range	16,610 - 16,850
52-Week Range	14,700 - 24,600
Beta	-0.16
RSI	45.74
Earnings Date	Mar 21, 2025

About Macrogen

Macrogen, Inc. provides precision medicine and bio-engineering healthcare services in Korea and internationally. It offers personal healthcare services, including disease prediction and wellness genetic, and DTC genetic testing services; MyPETGENE, a genetic testing service for companion animals; clinical services, such as precision medicine, genetic testing for cancer risk, NGS-based genetic panel lab, and GCLP services; and single cell expert services comprising single cell multi-omics and spatial transcriptome analysis, and single cell (In S...

• Industry: Commercial Physical and Biological Research
• Founded: 1997
• Employees: 519
• Stock Exchange: KOSDAQ
• Ticker Symbol: 038290

Financial Performance

In 2023, Macrogen's revenue was 132.80 billion, a decrease of -4.19% compared to the previous year's 138.62 billion. Losses were -16.81 billion, -24.44% less than in 2022.